Publication

Byline

Location

Winds of change in Sun Pharma's $11.75 billion Organon acquisition announcement

India, April 28 -- Sun Pharmaceutical Industries on Monday announced the $11.75 billion acquisition of Organon & Co., in a seemingly aggressive push into the US market that has long decided the global... और पढ़ें


Dilip Shanghvi-led Sun Pharma's most expensive M&A deal signals fading allure of US generics business

New Delhi, April 28 -- Sun Pharmaceutical Industries Ltd on Monday announced the $11.75 billion acquisition of Organon & Co., in a seemingly aggressive push into the US market that has long decided th... और पढ़ें


Dilip Shanghvi-led Sun Pharma's most expensive M&A deal signals fading allure of US generics business

New Delhi, April 28 -- Sun Pharmaceutical Industries Ltd on Monday announced the $11.75 billion acquisition of Organon & Co., in a seemingly aggressive push into the US market that has long decided th... और पढ़ें


Winds of change in Sun Pharma's Organon deal

Mumbai, April 28 -- Sun Pharmaceutical Industries on Monday announced the $11.75 billion acquisition of Organon & Co., in a seemingly aggressive push into the US market that has long decided the globa... और पढ़ें


The night the glow faded: Inside the unprecedented silence of Morbi

Mumbai, March 22 -- On most nights, Morbi glows. The light comes from hundreds of ceramic kilns firing through the darkness, turning clay into tiles that travel across India and into markets as far a... और पढ़ें


Siemens bets on private capex revival in India, sees local businesses leapfrog to AI-led automation

New Delhi, March 11 -- When Sunil Mathur was given a five-year extension two years ago, Siemens in India was already a compelling story. Today, with three years still left on his clock, the narrative ... और पढ़ें


Penicillin shot: Will Aurobindo Pharma's audacious bet rejuvenate antibiotic production in India?

Mumbai, Feb. 25 -- Nearly two decades after Indian manufacturers exited Penicillin G production-most notably when Torrent Pharma shut its plant in 2007-Aurobindo Pharma is staging what can only be des... और पढ़ें


Velumani's second coming: Why the Thyrocare founder wants a bite of the crowded dental market

Mumbai, Feb. 11 -- On most Saturdays, between the whir of drills and the shuffle of patient files in a busy suburban Mumbai dental clinic, you might find a 66-year-old entrepreneur bent over a whitebo... और पढ़ें